← Open Payments lookup

EMINA EFENDIC: Open Payments

NPI 1093363301 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,294 in 15 payments from 9 companies in 2025. Trend: 2023 $383 · 2024 $1,298 · 2025 $1,294

Food & beverage: $1,294
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$242
Axsome Therapeutics, Inc.2$237
E.R. Squibb & Sons, L.L.C.4$158
Janssen Pharmaceuticals, Inc2$143
Vanda Pharmaceuticals Inc.1$125
ABBVIE INC.1$125
Otsuka America Pharmaceutical, Inc.1$122
Alkermes, Inc.1$121
Luye Pharma (USA) Ltd.1$20

Products named: CAPLYTA, Auvelity, COBENFY, INVEGA SUSTENNA, FANAPT, VRAYLAR, ABILIFY MAINTENA, LYBALVI.

Industry payments across CT — which companies pay providers there.